{"meta":{"query_hash":"e249080cbcb8","filters":{"venue":"Fibrosis"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e249080cbcb8","api":"https://metacan.xera.ac/api/v1/cohort?venue=Fibrosis"},"results":[{"id":"W4414971312","doi":"10.70322/fibrosis.2025.10010","title":"Is “CTGF” Still a Viable Anti-Fibrotic Target?","year":2025,"lang":"en","type":"article","venue":"Fibrosis","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Drug development; Diabetes mellitus; Drug; Diabetic nephropathy; Subject (documents)","score_opus":0.013746720425750118,"score_gpt":0.2958039140115761,"score_spread":0.282057193585826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414971312","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027474674,0.014266608,0.00021933255,0.95789254,0.025990043,0.0000035820985,0.000021784133,0.00001105051,0.0013203524],"genre_scores_gemma":[0.009158047,0.027712757,0.00055100507,0.89586055,0.061183665,0.000020132411,0.000023040971,0.000045252287,0.0054454673],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955089,0.0016029773,0.000422344,0.0009717539,0.001118212,0.00037575804],"domain_scores_gemma":[0.975875,0.01832867,0.0010724176,0.00037942646,0.0035248552,0.00081966474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006071744,0.0006525248,0.0010309888,0.00072674855,0.0032270274,0.0042388993,0.003158594,0.024299935,0.0031197101],"category_scores_gemma":[0.024097186,0.0003626255,0.00068725616,0.0006144061,0.013829705,0.0064107394,0.002043855,0.03258588,0.0021214231],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013059881,0.000021356913,0.00027186962,0.0007663131,0.000036175894,0.0007796468,0.0019810952,0.00013793932,0.0012839807,0.04648566,0.91264904,0.035456367],"study_design_scores_gemma":[0.000021248768,0.000041590294,0.0003422389,0.00085183093,0.000017331562,0.0006522792,0.0016773178,0.000112506576,0.00068530306,0.021142986,0.9744038,0.000051610754],"about_ca_topic_score_codex":0.010982913,"about_ca_topic_score_gemma":0.015343187,"teacher_disagreement_score":0.024299935,"about_ca_system_score_codex":0.0042545223,"about_ca_system_score_gemma":0.0053203925,"threshold_uncertainty_score":0.03211087},"labels":[],"label_agreement":null}]}